© Illustration: Lydia Ballarin / Foto: P. Jaturawutthichai


Mag. Dr. Elke Luger
German Rheumatism Research Center Berlin (DRFZ)
Tel.: +49 30 / 28460 - 737

Chronic Inflammation

Leibniz ScienceCampus Berlin

Arthritis, multiple sclerosis, colitis, type-2 diabetes – millions of people in Germany suffer from chronic inflammatory diseases. Those affected have constant pain of the joints, skin, nervous system or gut – any organ can be affected.

Patients suffer a severe negative impact on day-to-day life. Some of these illnesses even prove to be fatal. Modern therapies have so far only managed to suppress the symptoms. In most cases, they are unable to actually cure the illness.

This is precisely what the researchers at the Leibniz ScienceCampus Berlin “Chronic Inflammation” are seeking to change. To this end, doctors and scientists from various specialist fields such as rheumatology, gastroenterology, neuropathology and dermatology are working together at the Charité Hospital and the German Rheumatism Research Centre Berlin. Working across different disciplines, they research and contrast the causes and mechanisms of chronic inflammatory diseases.

Their work pursues several long-term objectives. If a successful treatment already exists for a certain illness, the aim is to transfer it more rapidly to other diseases and thereby help more of those affected. Another objective is to optimally tailor therapies to individual patients and potentially even find a cure for the respective illness. Those interested can learn about this research by attending the public “LeibnizCharitéCampus Lectures”. The “LeibnizCharité-Entzündungssprechstunde” is another new offering, where doctors from different fields jointly consult with patients.


Prof. Andreas Radbruch
German Rheumatism Research Center Berlin (DRFZ)
Tel.: 030-28460-601

Prof. Axel Radlach Pries
Charité - Universitätsmedizin Berlin
Tel.: 030 / 450 570 251



Leibniz Institute:
German Rheumatism Research Center Berlin (DRFZ)

Charité - Universitätsmedizin Berlin

Further partners:
Max Planck Institute for Infection Biology, Berlin